Position in GSK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$204,438
-$11,686 QoQ
Shares Held
3,900
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#725
of 1,033 holders
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Architects, LLC holds $10,190,838 across 8 Drug Manufacturers - General names. GSK ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,001 | $3,599,489 | |
| 2 | JNJ |
Johnson & Johnson
|
8,211 | $2,085,347 | |
| 3 | MRK |
Merck & Co., Inc.
|
13,630 | $1,751,455 | |
| 4 | ABBV |
AbbVie Inc.
|
4,832 | $1,215,924 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,000 | $505,360 | |
| 6 | AMGN |
Amgen Inc
|
1,389 | $502,984 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,655 | $325,841 | |
| 8 | GSK |
GSK plc
This page
|
3,900 | $204,438 |
All Filings in GSK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $204,438 | 3,900 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $216,124 | 3,916 | Shares | Sole | 2026-05-15 | |
| 2022-06-30 | $206,938 | 4,847 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $206,910 | 4,843 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $207,356 | 4,794 | Shares | Sole | 2022-01-19 | |
| 2021-06-30 | $203,908 | 5,221 | Shares | Sole | 2021-08-09 | |
| 2020-06-30 | $204,034 | 5,100 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||